IBDEI03K ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4284,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,4284,1,5,0)
 ;;=5^Testicular Cancer
 ;;^UTILITY(U,$J,358.3,4284,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,4285,0)
 ;;=198.7^^38^302^2
 ;;^UTILITY(U,$J,358.3,4285,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4285,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,4285,1,5,0)
 ;;=5^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,4285,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,4286,0)
 ;;=198.5^^38^302^15
 ;;^UTILITY(U,$J,358.3,4286,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4286,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,4286,1,5,0)
 ;;=5^Bone Or Bone Marrow Metastasis
 ;;^UTILITY(U,$J,358.3,4286,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,4287,0)
 ;;=198.3^^38^302^17
 ;;^UTILITY(U,$J,358.3,4287,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4287,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,4287,1,5,0)
 ;;=5^Brain Metatastasis
 ;;^UTILITY(U,$J,358.3,4287,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,4288,0)
 ;;=197.7^^38^302^29
 ;;^UTILITY(U,$J,358.3,4288,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4288,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,4288,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,4288,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,4289,0)
 ;;=197.0^^38^302^86
 ;;^UTILITY(U,$J,358.3,4289,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4289,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,4289,1,5,0)
 ;;=5^Mets To Lung
 ;;^UTILITY(U,$J,358.3,4289,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,4290,0)
 ;;=196.2^^38^302^85
 ;;^UTILITY(U,$J,358.3,4290,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4290,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,4290,1,5,0)
 ;;=5^Mets To Ln, Abdominal
 ;;^UTILITY(U,$J,358.3,4290,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,4291,0)
 ;;=196.3^^38^302^87
 ;;^UTILITY(U,$J,358.3,4291,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4291,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,4291,1,5,0)
 ;;=5^Mets To Lymph Nodes, Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,4291,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,4292,0)
 ;;=196.0^^38^302^88
 ;;^UTILITY(U,$J,358.3,4292,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4292,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,4292,1,5,0)
 ;;=5^Mets To Lymph Nodes, Cervical
 ;;^UTILITY(U,$J,358.3,4292,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,4293,0)
 ;;=196.1^^38^302^89
 ;;^UTILITY(U,$J,358.3,4293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4293,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,4293,1,5,0)
 ;;=5^Mets To Lymph Nodes, Mediastinal 
 ;;^UTILITY(U,$J,358.3,4293,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,4294,0)
 ;;=196.8^^38^302^90
 ;;^UTILITY(U,$J,358.3,4294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4294,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,4294,1,5,0)
 ;;=5^Mets To Lymph Nodes, Multiple Sites
 ;;^UTILITY(U,$J,358.3,4294,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,4295,0)
 ;;=V10.51^^38^302^47
 ;;^UTILITY(U,$J,358.3,4295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4295,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,4295,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,4295,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,4296,0)
 ;;=V10.3^^38^302^48
 ;;^UTILITY(U,$J,358.3,4296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4296,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,4296,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,4296,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,4297,0)
 ;;=V10.41^^38^302^49
 ;;^UTILITY(U,$J,358.3,4297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4297,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,4297,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,4297,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,4298,0)
 ;;=V10.05^^38^302^50
 ;;^UTILITY(U,$J,358.3,4298,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4298,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,4298,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,4298,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,4299,0)
 ;;=V10.03^^38^302^51
 ;;^UTILITY(U,$J,358.3,4299,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4299,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,4299,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,4299,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,4300,0)
 ;;=V10.60^^38^302^53
 ;;^UTILITY(U,$J,358.3,4300,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4300,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,4300,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,4300,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,4301,0)
 ;;=V10.11^^38^302^54
 ;;^UTILITY(U,$J,358.3,4301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4301,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,4301,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,4301,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,4302,0)
 ;;=V10.79^^38^302^55
 ;;^UTILITY(U,$J,358.3,4302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4302,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,4302,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,4302,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,4303,0)
 ;;=V10.82^^38^302^56
 ;;^UTILITY(U,$J,358.3,4303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4303,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,4303,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,4303,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,4304,0)
 ;;=V10.02^^38^302^57
 ;;^UTILITY(U,$J,358.3,4304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4304,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,4304,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,4304,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,4305,0)
 ;;=V10.43^^38^302^58
 ;;^UTILITY(U,$J,358.3,4305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4305,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,4305,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,4305,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,4306,0)
 ;;=V10.46^^38^302^59
 ;;^UTILITY(U,$J,358.3,4306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4306,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,4306,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,4306,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,4307,0)
 ;;=V10.06^^38^302^60
 ;;^UTILITY(U,$J,358.3,4307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4307,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,4307,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,4307,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,4308,0)
 ;;=V10.52^^38^302^61
 ;;^UTILITY(U,$J,358.3,4308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4308,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,4308,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,4308,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,4309,0)
 ;;=V10.04^^38^302^63
 ;;^UTILITY(U,$J,358.3,4309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4309,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,4309,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,4309,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,4310,0)
 ;;=V10.47^^38^302^64
 ;;^UTILITY(U,$J,358.3,4310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4310,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,4310,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,4310,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,4311,0)
 ;;=V10.83^^38^302^62
 ;;^UTILITY(U,$J,358.3,4311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4311,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,4311,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,4311,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,4312,0)
 ;;=285.22^^38^302^8
 ;;^UTILITY(U,$J,358.3,4312,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4312,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,4312,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,4312,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,4313,0)
 ;;=285.21^^38^302^9
 ;;^UTILITY(U,$J,358.3,4313,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4313,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,4313,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,4313,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,4314,0)
 ;;=285.29^^38^302^10
 ;;^UTILITY(U,$J,358.3,4314,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4314,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,4314,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,4314,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,4315,0)
 ;;=284.9^^38^302^11
 ;;^UTILITY(U,$J,358.3,4315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4315,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,4315,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,4315,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,4316,0)
 ;;=282.61^^38^302^67
 ;;^UTILITY(U,$J,358.3,4316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4316,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,4316,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,4316,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,4317,0)
 ;;=282.7^^38^302^66
 ;;^UTILITY(U,$J,358.3,4317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4317,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,4317,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,4317,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,4318,0)
 ;;=283.9^^38^302^69
 ;;^UTILITY(U,$J,358.3,4318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4318,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,4318,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,4318,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,4319,0)
 ;;=283.0^^38^302^70
 ;;^UTILITY(U,$J,358.3,4319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4319,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,4319,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,4319,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,4320,0)
 ;;=282.9^^38^302^68
 ;;^UTILITY(U,$J,358.3,4320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4320,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,4320,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,4320,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,4321,0)
 ;;=283.19^^38^302^71
 ;;^UTILITY(U,$J,358.3,4321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4321,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,4321,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,4321,2)
 ;;=^293664
